Omnicell, Inc. Profile Avatar - Palmy Investing

Omnicell, Inc.

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve cli…
Medical - Healthcare Information Services
US, Mountain View [HQ]

Ratios

15 Sheets · Starting from 2023
Margins, Growth Rates In %
Ratio 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Profitability
Gross Margin
49.29 53.02 55.30 54.31 53.44 53.04 51.17 45.31 44.97 47.29 48.71 46.32 49.00 45.45 43.58
Profit Margin
0.21 2.20 4.23 5.15 6.30 6.92 6.35 0.09 2.88 4.79 6.84 3.61 6.88 0.44 -1.78
Operating Margin
0.31 4.28 6.61 8.62 9.27 11.25 10.04 0.94 0.80 5.64 8.73 3.98 7.91 -0.18 -1.69
EPS Growth
-97.50 1,400.00 106.67 58.07 40.82 24.64 - - -68.61 200.00 18.52 54.17 -48.65 135.53 -92.74 -446.15
Return on Assets (ROA)
0.14 1.42 2.87 3.64 4.87 5.45 5.31 0.06 2.10 3.49 4.94 1.76 3.63 0.26 -0.91
Return on Equity (ROE)
0.18 1.84 3.67 5.25 6.88 7.82 7.64 0.14 3.98 5.55 7.26 3.33 6.79 0.50 -1.71
Return on Invested Capital (ROIC)
0.11 1.83 3.86 5.18 6.83 7.90 7.88 -0.29 -18.54 5.71 6.80 2.61 6.30 0.31 -1.11
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
-3.30 -2.85 -3.26 1.07 1.14 0.86 1.44 27.18 21.44 13.36 8.92 28.96 24.65 27.90 26.05
Debt/Equity
-4.37 -3.68 -4.17 1.54 1.62 1.24 2.07 58.88 40.63 21.25 13.10 54.60 46.05 54.57 48.80
Debt/EBITDA
-6,096.18 -1,539.44 -1,172.50 -230.08 -296.13 -253.89 -122.01 307.90 310.31 71.26 -18.63 28.16 102.62 295.70 148.38
Debt/Capitalization
-4.57 -3.82 -4.35 1.52 1.59 1.22 2.03 37.06 28.89 17.52 11.58 35.32 31.53 35.31 32.79
Interest Debt per Share USD
-0.33 -0.30 -0.35 0.14 0.17 0.11 0.17 6.80 5.43 3.46 2.56 12.26 11.61 13.89 12.93
Debt Growth
- - - - - - - - - - - - - - - - -17.32 -35.55 -25.66 412.67 2.32 16.79 -0.43
Liquidity
Current Ratio
435.92 463.20 475.57 212.84 251.19 252.28 211.93 174.34 172.73 194.12 203.90 300.05 89.11 205.82 252.20
Quick Ratio
367.41 390.66 403.02 138.18 175.28 185.75 152.59 113.20 104.29 128.77 145.81 248.28 68.55 149.68 211.19
Cash Ratio
293.65 303.01 326.41 73.32 112.32 112.07 65.97 30.12 15.26 32.84 53.68 175.79 39.84 77.11 136.21
Operating Cash Flow Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Turnover
Inventory Turnover
1,129.58 1,067.86 606.13 533.30 563.26 656.15 507.85 546.67 409.91 411.41 425.99 497.33 481.44 479.14 587.82
Receivables Turnover
502.12 520.47 665.37 569.76 649.50 532.73 448.84 460.82 378.47 401.20 410.80 469.29 469.92 432.75 434.69
Payables Turnover
1,049.51 789.08 997.74 785.90 1,075.75 1,065.46 1,044.90 1,399.47 816.06 1,090.96 992.06 1,188.11 807.36 1,115.27 1,437.29
Asset Turnover
66.43 64.78 67.83 70.77 77.28 78.70 83.73 74.07 73.06 72.82 72.29 48.90 52.84 58.62 51.51
Coverage
Interest Coverage
4,460.00 238,150.00 26,164.52 93,389.66 28,933.61 -4,595.27 -2,036.52 -76.89 -86.75 -505.83 -1,773.07 -575.13 -380.88 -1,786.92 -426.78
Asset Coverage
- - - - - - - - - - - - - - 200 200 500 800 200 200 200 200
Cash Flow Coverage (CFGR)
-407.39 -210.93 -264.79 833.70 981.06 1,348.01 405.45 18.86 11.82 71.99 130.96 35.18 43.90 12.61 31.21
EBITDA Coverage
18,500 285,200 26,300 93,300 28,900 -4,500 -2,800 -700 -800 -1,000 -3,200 -1,700 -700 74,400 1,600
Dividend Coverage
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Time Interest Earned (TIE)
100 100 100 100 100 100 100 100 100 100 100 100 100 - - - -
Market Prospects
Dividend Yield
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Yield
0.12 1.04 1.90 3.26 2.70 2.59 2.76 0.05 1.13 1.57 1.81 0.63 0.99 0.25 -1.20
Price/Earnings (P/E)
83,438.69 9,644.46 5,267.03 3,064.63 3,698.28 3,868.96 3,623.00 203,265.07 8,822.74 6,369.58 5,523.94 15,875.04 10,076.72 39,634.33 -8,351.71
Price/Book (P/B)
152.89 177.71 193.41 161.02 254.59 302.67 276.96 283.98 351.49 353.61 400.86 528.25 684.11 198.08 143.09
Price/Sales (P/S)
173.56 212.14 222.86 157.72 233.01 267.80 229.99 176.96 253.84 305.24 377.72 572.83 692.98 172.73 148.31
Price/Cash Flow (P/CF)
858.96 2,290.44 1,751.41 1,254.37 1,604.71 1,811.96 3,300.86 2,556.87 7,320.31 2,311.51 2,336.61 2,749.67 3,384.09 2,878.01 939.47
End of OMCL's Analysis
CIK: 926326 CUSIP: 68213N109 ISIN: US68213N1090 LEI: - UEI: -
Secondary Listings
OMCL has no secondary listings inside our databases.